Deep proteome coverage advances knowledge of Treponema pallidum protein expression profiles during infection

Simon Houston1, Alloysius Gomez1, Andrew Geppert1

  • 1Department of Biochemistry and Microbiology, University of Victoria, Victoria, BC, Canada.

Scientific Reports
|October 25, 2023
PubMed

Insights

Researchers optimized proteomic analysis for Treponema pallidum (syphilis spirochete), identifying 77% of its proteins during infection. This deep proteome coverage advances understanding of syphilis pathogenesis and potential vaccine targets.

Area of Science:

  • Microbiology
  • Proteomics
  • Infectious Diseases

Background:

  • Comprehensive proteome analysis of Treponema pallidum is hindered by sample complexity and bacterial fragility.
  • Identifying rare outer membrane proteins (OMPs) in T. pallidum presents significant proteomic challenges.

Purpose of the Study:

  • To optimize a sample preparation and mass spectrometry pipeline for T. pallidum proteome analysis.
  • To gain a deeper understanding of the T. pallidum global proteome expression profile under infection conditions.
  • To identify novel outer membrane proteins (OMPs) and potential vaccine candidates.

Main Methods:

  • Development and optimization of a T. pallidum-specific sample preparation workflow.
  • Application of a mass spectrometry-based proteomics pipeline for large-scale protein identification.
  • Integration of new data with prior proteomic studies for comprehensive coverage.

Main Results:

  • Detection of 77% of the T. pallidum protein repertoire under infection conditions.
  • Achieved nearly 90% overall proteome coverage when combined with previous studies.
  • Identified 27 known/predicted OMPs and detected 11 novel OMPs during infection for the first time.

Conclusions:

  • The optimized pipeline offers a robust method for studying T. pallidum protein expression during infection.
  • This study provides the deepest proteome coverage of T. pallidum to date.
  • Findings enhance genome annotations and identify potential vaccine candidates for syphilis.